FDA expands VOXZOGO approval for all ages with open growth plates
BioMarin Pharmaceutical Inc., a leading global biotechnology entity, unveiled that its drug, VOXZOGO (vosoritide), has received the green light from the U.S. Food and Drug Administration (FDA) to enhance linear growth in pediatric patients of all ages with open epiphyses (growth plates) suffering from achondroplasia. Key Highlights from the Approval Previously, the drug’s indication was […]